Tapewire

Nasdaq · USD

CPIX

CUMBERLAND PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
6757
SEC CIK
0001087294
Parsed reports
362

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 22, 2015 Filed Dec 22, 2017 22:01 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
GiftCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-067091 · doc4.xml · nonDerivative · entry 1

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,830,270

F1 · shares: Transaction is a charitable donation

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.